The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | Geriatric assessment-guided treatment in older AML: cognitive and functional predictors
Vijaya Bhatt, MBBS, University of Nebraska Medical Center, Omaha, NE, discusses findings from a Phase II trial (NCT03226418) using geriatric assessment to guide treatment intensity in older adults with acute myeloid leukemia (AML). He highlights how cognitive and cumulative functional impairments predict survival and inform personalized care. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
